Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation-Reference-Cited by-同舟云学术

Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation

Published:2019-01 Issue: Volume:275 Page:95-100
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Dannenberg Lisa,Mourikis Philipp,Naguib David,Zako Saif,Helten Carolin,M'Pembele René,Trojovsky Kajetan,Konsek Daniel,Wolff Georg,Brockmeyer Maximilian,Schulze Volker,Levkau Bodo,Hohlfeld Thomas,Zeus Tobias,Kelm Malte,Polzin Amin

Funder

Heinrich Heine University

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study;Stewart;Am. J. Med.,2002

2. Improving stroke risk stratification in atrial fibrillation;Lip;Am. J. Med.,2010

3. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk;Potpara;Prog. Cardiovasc. Dis.,2015

4. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries;Steinberg;Am. Heart J.,2017

5. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials;Reddy;J. Am. Coll. Cardiol.,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Antithrombotic Regimen in Left Atrial Appendage Occlusion: The Gordian Knot?;Pharmacology;2022-12-13

2. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review;Thrombosis Research;2022-07

3. Left atrial appendage occlusion in haemophilia patients with atrial fibrillation;Journal of Interventional Cardiac Electrophysiology;2021-11-25

4. MirSNPs in clopidogrel metabolism genes predict cardiovascular disease risk: a case–control study and meta-analysis;Pharmacogenomics;2021-01

5. Enhanced Platelet Reactivity under Aspirin Medication and Major Adverse Cardiac and Cerebrovascular Events in Patients with Coronary Artery Disease;Pharmacology;2019-10-22